APA (7th ed.) Citation

Horan, J., Qayed, M., Haight, A., Couture, C., Chiang, K., & Kean, L. (2012). Targeting Memory T Cells with Alefacept to Abrogate Transfusion Alloimmunization: Preliminary Results from a Trial of Reduced Intensity Conditioning and Allogeneic Transplant for Children with Non-Malignant Hematologic Diseases. Biology of Blood & Marrow Transplantation, 18(2), S325. https://doi.org/10.1016/j.bbmt.2011.12.316

Chicago Style (17th ed.) Citation

Horan, J.T, M. Qayed, A. Haight, C. Couture, K.Y Chiang, and L. Kean. "Targeting Memory T Cells with Alefacept to Abrogate Transfusion Alloimmunization: Preliminary Results from a Trial of Reduced Intensity Conditioning and Allogeneic Transplant for Children with Non-Malignant Hematologic Diseases." Biology of Blood & Marrow Transplantation 18, no. 2 (2012): S325. https://doi.org/10.1016/j.bbmt.2011.12.316.

MLA (9th ed.) Citation

Horan, J.T, et al. "Targeting Memory T Cells with Alefacept to Abrogate Transfusion Alloimmunization: Preliminary Results from a Trial of Reduced Intensity Conditioning and Allogeneic Transplant for Children with Non-Malignant Hematologic Diseases." Biology of Blood & Marrow Transplantation, vol. 18, no. 2, 2012, p. S325, https://doi.org/10.1016/j.bbmt.2011.12.316.